Albuquerque, NM, United States of America

Scarlett Swanson


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: **Celebrating the Innovations of Inventor Scarlett Swanson**

Introduction

Scarlett Swanson, a pioneering inventor based in Albuquerque, NM, has made significant strides in the field of medical diagnostics. With two patents to her name, she is at the forefront of developing innovative solutions to enhance healthcare and combat serious infections.

Latest Patents

Her latest inventions include "Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections." This remarkable work provides a method for accurately diagnosing sepsis or virus-related infections by detecting and measuring biomarkers associated with these conditions in a sample obtained from patients. Utilizing multiplexed flow cytometry, her invention offers point-of-care diagnostic methods, which are critical in determining the early stages of sepsis or the severity of viral infections in hospital settings.

Career Highlights

Throughout her career, Swanson has contributed her expertise to several organizations, including UNM Rainforest Innovations, where her work has fostered advancements in diagnostic technology. Her dedication to research and development in the biomedical field has positioned her as a respected figure among her peers.

Collaborations

Scarlett has collaborated with fellow researchers such as Tione Buranda and Jacob Ongudi Agola, emphasizing the importance of teamwork in the pursuit of scientific innovation. These collaborations have played a vital role in driving forward the impact of her inventions and advancing the health sector.

Conclusion

With her innovative spirit and commitment to excellence, Scarlett Swanson is undoubtedly a valuable contributor to the field of medical diagnostics. Her patents are not only a testament to her inventiveness but also a beacon of hope for improved patient outcomes in the face of critical infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…